Literature DB >> 21371075

Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis.

Kei Sakamoto1, Tadanobu Aragaki, Kei-ichi Morita, Hiroshi Kawachi, Kou Kayamori, Shoichi Nakanishi, Ken Omura, Yoshio Miki, Norihiko Okada, Ken-Ichi Katsube, Toichiro Takizawa, Akira Yamaguchi.   

Abstract

AIMS: This study aimed to identify relevant keratin subtypes that may associate with the pathogenesis of oral epithelial neoplasms. METHODS AND
RESULTS: Expression of all the keratin subtypes was examined by cDNA microarray analysis of 43 oral squamous cell carcinoma (OSCC) cases. Immunohistochemical expression of the major keratins was examined in 100 OSCC and oral epithelial dysplasia (OED) cases. Many changes in keratin expression were observed and, significantly, consistent down-regulation of keratin 4 (K4) and K13 expression was observed. Aberrant expression of K4 and K13 was associated with morphological changes in the affected oral epithelium. Experiments with cell cultures transfected with various keratin subtypes suggested that alterations in keratin subtype expression can cause changes in cell shape and movement.
CONCLUSIONS: Aberrant expression of K4 and K13, which are the dominant pair of differentiation-related keratins in oral keratinocytes, indicates dysregulation of epithelial differentiation in OSCC and OED. These keratins, especially K4, may be useful for pathological diagnosis. We propose that the aberrant expression of K4 and K13 and concomitant up-regulation of the other keratins may be one of the causative factors for morphological alterations in the affected epithelium.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371075     DOI: 10.1111/j.1365-2559.2011.03759.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  29 in total

1.  Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation.

Authors:  John Schomberg; Argyrios Ziogas; Hoda Anton-Culver; Trina Norden-Krichmar
Journal:  Oral Oncol       Date:  2018-02-20       Impact factor: 5.337

2.  Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.

Authors:  Subin Surendran; Gangotri Siddappa; Amrutha Mohan; Wesley Hicks; Vijayvel Jayaprakash; Christina Mimikos; Mohammed Mahri; Fatima Almarzouki; Kayla Morrell; Ravindra Ravi; Sindhu Govindan; C N Sushma; Nisheena Raghavan; Praveen Birur; Jeyaram Ilayaraja; Mihai Merzianu; Mary Reid; Amritha Suresh; Moni Abraham Kuriakose
Journal:  Oral Oncol       Date:  2017-11-12       Impact factor: 5.337

3.  Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.

Authors:  Mara Gilardi; Zhiyong Wang; Marco Proietto; Anastasia Chillà; Juan Luis Calleja-Valera; Yusuke Goto; Marco Vanoni; Matthew R Janes; Zbigniew Mikulski; Antonio Gualberto; Alfredo A Molinolo; Napoleone Ferrara; J Silvio Gutkind; Francis Burrows
Journal:  Mol Cancer Ther       Date:  2020-07-29       Impact factor: 6.261

4.  Interrogation of RDEB Epidermal Allografts after BMT Reveals Coexpression of Collagen VII and Keratin 15 with Proinflammatory Immune Cells and Fibroblasts.

Authors:  Julia A Riedl; Megan Riddle; Lily Xia; Cindy Eide; Christina Boull; Christen L Ebens; Jakub Tolar
Journal:  J Invest Dermatol       Date:  2022-03-15       Impact factor: 7.590

5.  Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.

Authors:  W Nittayananta; W Mitarnun; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2012-07-02       Impact factor: 3.511

6.  Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease.

Authors:  Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano
Journal:  COPD       Date:  2013-08       Impact factor: 2.409

7.  Loss of cytokeratin 10 indicates malignant transformation in actinic cheilitis.

Authors:  Natália Galvão Garcia; Denise Tostes Oliveira; José Roberto Pereira Lauris; Maria Aparecida Custódio Domingues; Eliana Maria Minicucci; Cléverson Teixeira Soares
Journal:  Clin Oral Investig       Date:  2015-08-13       Impact factor: 3.573

8.  Two mechanisms regulate keratin K15 expression in keratinocytes: role of PKC/AP-1 and FOXM1 mediated signalling.

Authors:  Amrita Bose; Muy-Teck Teh; Iain L Hutchison; Hong Wan; Irene M Leigh; Ahmad Waseem
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

9.  S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.

Authors:  Dipak Sapkota; Ove Bruland; Himalaya Parajuli; Tarig A Osman; Muy-Teck Teh; Anne C Johannessen; Daniela Elena Costea
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

10.  Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx.

Authors:  Jayalakshmi Nair; Prachi Jain; Udita Chandola; Vinayak Palve; N R Harsha Vardhan; Ram Bhupal Reddy; Vikram D Kekatpure; Amritha Suresh; Moni Abraham Kuriakose; Binay Panda
Journal:  Genes Cancer       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.